General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
Comprehensive Educational Services (ACES) is a leading provider of applied behavioral analysis and ancillary services to individuals and families impacted with autism or other special needs.
Royalty Pharma ×
Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.